New variants of HA and NA might contribute to the emergence of new clinical characteristics, for example, HA-D239E mutation was associated with mild infection, been less severe than HA-D239G and D239N [9], and NA-H275Y, NA-E119D conferred resistance to neuraminidase inhibitors [10, 11]. This evidence concerns the gene XK and infection.